Overview
BTSG market data
Price History
BTSG price chart
Valuation & Profitability
- P/E (TTM)
- 32.56 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.87 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.83 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 2.6% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $21.58 – $73.75 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $11.9B · P/B 3.60 · P/S 0.83.
Company News
BTIG Reiterates Buy on BrightSpring Health, Maintains $90 Price TargetBenzinga · Aug 13, 2026, 10:53 AM
BrightSpring Health Services shares are trading lower despite reporting better-than-expected Q2 financial results and raising its FY26 sales guidance above estimates. The stock has gained over 600% in two years.Benzinga · Jul 31, 2026, 2:23 PM
BrightSpring Health Q2 Adj. EPS $0.45 Beats $0.40 Estimate, Sales $3.873B Beat $3.658B EstimateBenzinga · Jul 31, 2026, 10:00 AM
BrightSpring Health Raises FY2026 Sales Guidance from $14.725B-$15.225B to $15.100B-$15.425B vs $15.064B EstBenzinga · Jul 31, 2026, 10:00 AM
BrightSpring Health Services To Replace Chart Industries In The S&P MidCap 400, And Karman Holdings To Replace BrightSpring Health Services In The S&P SmallCap 600 Effective Prior To The Opening Of Trading On Friday, July 17Benzinga · Jul 14, 2026, 9:23 PM
Morgan Stanley Maintains Overweight on BrightSpring Health, Raises Price Target to $80Benzinga · Jul 14, 2026, 12:42 PM
Keybanc Maintains Overweight on BrightSpring Health, Raises Price Target to $80Benzinga · Jul 14, 2026, 11:51 AM
Wells Fargo Maintains Overweight on BrightSpring Health, Raises Price Target to $78Benzinga · Jul 13, 2026, 1:34 PM
Guggenheim Initiates Coverage On BrightSpring Health with Buy Rating, Announces Price Target of $81Benzinga · Jul 13, 2026, 12:32 PM
This Travelers Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For FridayBenzinga · Jul 10, 2026, 11:50 AM